Federal Appeals Court Upholds BRCA1/2 Decision Against Myriad Genetics | GenomeWeb

NEW YORK (GenomeWeb News) – The US Court of Appeals for the Federal Circuit today upheld an earlier decision denying Myriad Genetics' request for an injunction against Ambry Genetics to prevent it from marketing a BRCA1 and BRCA2 gene test.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.